Overview

Azithromycin in the Treatment of M. Avium Complex Lung Disease

Status:
Completed
Trial end date:
2017-05-18
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of azithromycin in the treatment of lung infection with M.avium complex and M. abscessus lung disease.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at Tyler
Collaborator:
Pfizer
Treatments:
Azithromycin